期刊文献+

Toll样受体4在MPTP帕金森病小鼠模型十二指肠和远端结肠的表达 被引量:3

Expression of TLR4 in Duodenum and Distal Colon of Mice with MPTP-induced Parkinson's Disease
下载PDF
导出
摘要 目的初步探讨1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)帕金森病小鼠模型十二指肠和远端结肠细菌内毒素受体Toll样受体4(TLR4)表达的变化。方法成年雄性C57BL/6小鼠随机分为4组:PBS对照3d组,PBS对照7d组,MPTP帕金森病小鼠3d组,MPTP帕金森病小鼠7d组,MPTP帕金森病小鼠模型组给予MPTP(20mg/kg,3次,每次间隔2h),PBS对照组给予等量PBS。在末次处理后3d或7d处死小鼠,取出十二指肠和远端结肠组织。采用免疫印迹法检测TLR4的表达,采用免疫组化法检测TLR4阳性细胞表达。结果在MPTP帕金森病小鼠7d组,十二指肠、远端结肠TLR4蛋白表达均显著增加(均P<0.05)。结论 MPTP帕金森病小鼠模型十二指肠和远端结肠TLR4上调可能与帕金森病的病理生理进程相关。 Objective To investigate the change of the expression of TLR4 in the duodenum and distal colon of mice with MPTP-induced Parkinson's disease. Methods Adult C57BL/6 mice were randomly divided into four groups:two normal con trol groups(3,7 days)and two MPTP groups(3,7 days). Mice were sacrificed 3 or 7 days after PBS or MPTP administration Eintraperitoneal injection of PBS or MPTP(20 mg/kg,3 times at 2 h apart)]. The expression levels of TLR4 in the duodenmn and distal colon were detected by Western blot and immunohistochemistry. Results The TLR4 expression was significantly ele vated in the duodenum and distal colon 7 days after MPTP treatment, significantly higher than that in the normal control groups (P〈0.05). Conclusion The upregulation of TLR4 in specific areas of the intestine may be associated with the pathophysiology of MPTP-induced Parkinson's disease.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2014年第1期73-75,共3页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 江西省科技厅青年科学基金资助项目(No.20132BAB215037) 江西省教育厅青年科学基金资助项目(No.GJJ13030)
关键词 十二指肠 结肠 TOLL样受体4 帕金森病 duodenum colon toll like receptor 4 Parkinson's disease
  • 相关文献

参考文献2

二级参考文献19

  • 1Schapira A H. Monoamine oxidase B inhibitors for the treat- ment of Parkinsons disease:a review of symptomatic and po- tential disease-modifying effects [ J ]CNS Drugs, 2011, 25 (12) :1061-1071.
  • 2de la Fuente-Fernandez R,Schulzer M,Mak E,et al. Trials of neuroproteetive therapies t[or Parkinson s disease: problems and limitations [- J ] Parkinsonism Relat Disord, 2010,16 ( 6 ) : 365-369.
  • 3Hyman C, Hofer M, Barde Y A, et al. BDNF is a neurotrophlc factor for dopaminergic neurons of the substantia nigra[J]. Nature, 1991,350(6315) :230-232.
  • 4Jang S W, Liu X, Yepes M, et al. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone [J]. Proc Natl Acad Sci USA,2010,107(6) :2687-2692.
  • 5Chan C S, Gertler T S,Surmeier D J. A molecular basis for the increased vulnerability of substantla nigra dopamine neu- rons in aging and Parkinson's diseaserJ]. Mov Disord, 2010, 25(Suppl 1) :$63-$70.
  • 6Kupsch A, Gerlach M, Pupeter S C, et al. Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the ni- gral,hut not at the striata}, level in mice[J]. Neuroreport, 1995,6(4) :621-625.
  • 7Kupsch A, Sautter J,Schwarz J, et al. 1 Methyl-4-phenyl-1,2, 3, 6 tetrahydropyridine-indueed neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral,but not at the striatal level[J]. Brain Res, 1996, 741(1/2) :185 196.
  • 8Sautter J, Kupsch A, Earl C D, et al. Degeneration of pre-la- belled nigral neurons induced by intrastriatal 6 hydroxydo- pamine in the rat: behavioural and biochemical changes and pretrea tment with the calcium-entry blocker nimodipine[J]. Exp Brain Res,1997,117(1):111-119.
  • 9Ilijic E,Guzman J N,Surmeier D J. The L-type channel antag- onist isradipine is neuroprotective in a mouse model of Parkin- son's disease[J]. Neurobiol Dis,2011,43(2) :364-371.
  • 10Kirik D, Rosenblad C, Bj6rklund A. Characterization of behav- ioral and neurodegenerative changes following partial lesions o the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat[J]. Exp Neurol, 1998,152 (2) 259-277.

共引文献18

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部